Ryan Specialty (NYSE:RYAN) Releases Earnings Results, Misses Estimates By $0.02 EPS

Ryan Specialty (NYSE:RYAN) released its earnings results on Thursday. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02), Zacks reports. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The company had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million.

Ryan Specialty Stock Down 4.4 %

RYAN opened at $65.55 on Friday. The business’s fifty day moving average is $65.57 and its two-hundred day moving average is $67.26. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The company has a market cap of $17.16 billion, a price-to-earnings ratio of 95.00, a PEG ratio of 1.19 and a beta of 0.72. Ryan Specialty has a one year low of $45.72 and a one year high of $75.97.

Ryan Specialty Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 0.73%. This is an increase from Ryan Specialty’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend is Tuesday, March 4th. Ryan Specialty’s payout ratio is presently 63.77%.

Insider Activity

In other news, Director Nicholas Dominic Cortezi sold 10,485 shares of the company’s stock in a transaction on Thursday, January 23rd. The stock was sold at an average price of $65.12, for a total value of $682,783.20. Following the sale, the director now directly owns 11,109 shares in the company, valued at $723,418.08. This represents a 48.56 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have sold 316,451 shares of company stock worth $20,907,793 over the last three months. 11.10% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

RYAN has been the topic of a number of recent analyst reports. Royal Bank of Canada dropped their price objective on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a report on Friday. Wells Fargo & Company upped their price objective on Ryan Specialty from $64.00 to $69.00 and gave the stock an “equal weight” rating in a report on Friday. Barclays upped their price objective on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, November 21st. Keefe, Bruyette & Woods dropped their price objective on Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating on the stock in a report on Friday. Finally, Morgan Stanley initiated coverage on Ryan Specialty in a report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price objective on the stock. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $74.55.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.